---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285997804.md"
description: "AbCellera Biologics shares are trading higher after the company reported better-than-expected Q1 financial results."
datetime: "2026-05-11T20:56:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285997804.md)
  - [en](https://longbridge.com/en/news/285997804.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285997804.md)
---

# 

AbCellera Biologics shares are trading higher after the company reported better-than-expected Q1 financial results.

### Related Stocks

- [ABCL.US](https://longbridge.com/en/quote/ABCL.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)

## Related News & Research

- [Genprex data shows gene therapy reverses hyperglycemia in T2D mice at ASGCT](https://longbridge.com/en/news/286414681.md)
- [Regenxbio's muscle disorder therapy meets main goal in late-stage study](https://longbridge.com/en/news/286406339.md)
- [US cancer clinics scramble to get experimental Revolution Medicines pancreatic cancer drug](https://longbridge.com/en/news/286394551.md)
- [Acrivon Therapeutics, Inc. (ACRV) Receives a Buy from Oppenheimer](https://longbridge.com/en/news/286428001.md)
- [Full Transcript: Cellectar Biosciences Q1 2026 Earnings Call](https://longbridge.com/en/news/286422585.md)